AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
AI
Innoplexus Assists in Biomarker Identification
In 2019, Innoplexus worked with Novartis on a pilot program that used Innoplexus’s proprietary artificial intelligence solutions and publicly available data to seek to identify baseline biomarkers of response. Innoplexus was talking to Eric Hughes – global development unit head for immunology, hepatology, and dermatology at Novartis: What is your role at Novartis, and what …
Impact of AI and Digitalization on R&D in Biopharmaceutical Industry
Data are not the new gold – but the ability to put them together in a relevant and analyzable way is Innoplexus has contributed to big data and Artificial Intelligence (AI) projects in pharma R&D. In this paper we share our point of view on the impact of AI enabled technologies on R&D that can …
Impact of AI and Digitalization on R&D in Biopharmaceutical Industry Read More »
Why AI Is a Practical Solution for Pharma
Artificial intelligence, or AI, is gaining more attention in the pharma space these days. At one time evoking images from futuristic science fiction, it now plays a significant role in smartphones, cars, search engines, and financial transactions. But what, exactly, is artificial intelligence? It is a set of very specialized algorithms trained to solve very …
You Can’t Find the Needle If You Don’t Know It Exists
This blog is adapted from my book titled “Inside the Cockpit: Navigating the Complexity of Drug Development with AI and Blockchain”. Full copies are available here. In December 2014, a twenty-nine-year-old investor named Vivek Ramaswamy bought a patent from GlaxoSmithKline (GSK) for $5 million. The patent covered an Alzheimer’s drug candidate that had failed GSK’s …
You Can’t Find the Needle If You Don’t Know It Exists Read More »
Build KOL Connections and Leverage Their Networks to Influence Stakeholders
Key opinion leaders (KOLs) play a central role in creating brand value for a pharmaceutical company. They are not only the face of the brand for the outside world but also an irreplaceable resource within the company, bringing new insights and overall enhancement throughout the drug development process. So, who are the KOLs? When a …
Build KOL Connections and Leverage Their Networks to Influence Stakeholders Read More »
Can AI-Enhanced Data Analytics Accelerate Clinical Trials?
The success rate of clinical trials carries significant weight in the business of pharma. In addition to dedicating considerable time and effort, the industry spends billions on R&D every year. Clinical development requires optimal decision-making and multiple insights on various parameters, including identifying trial sites, recruiting patients, coordinating logistics, and overseeing research. Adding pressure to …
Can AI-Enhanced Data Analytics Accelerate Clinical Trials? Read More »
How Will AI Disrupt the Pharma Industry?
There is a lot of buzz these days about how artificial intelligence (AI) is going to disrupt the pharmaceutical industry. At one time a mere idea that was the subject of discussions around its possible and practical uses, these technologies are now a reality that is turning pharma into a more productive industry with game-changing …
Innoplexus’s Proprietary CAAV Framework for Intelligent Big Data Analysis
The amount of data currently being produced by the life sciences industry is exploding. Medical information alone is expected to double every 73 days by 2020,1 and much of this data is unstructured. If we want to put this extremely complex, vast ocean of data to use, we need to crawl, aggregate, analyze, and visualize …
Innoplexus’s Proprietary CAAV Framework for Intelligent Big Data Analysis Read More »
